Stock·NASDAQ·Technology
Okta Inc. (OKTA)
- Market cap
- $32.74B
- P/E
- 112.81
- Dividend yield
- 0.00%
- Street target
- $223.00median of 44 analysts
- 52-week range
- $62.66 $235.00
The short version
Where OKTA stands today, in four lines, and what CleaRank Financial AI makes of it.
OKTA at a glance
Okta Inc. (OKTA): Buy, 64/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($179.90 and $118.52).
- Earnings OKTA beat estimates in 7 of its last 7 quarters, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $68.4M and bought $267K over the last 18 months.
- Valuation P/E of 112.8 against 35.1 for the Technology sector: a premium to peers (+221%).
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates Okta Inc. (OKTA) Buy, with a model score of 64/100.
The trend lifts the score most: the price is 58.00% above its 200-day average and 4.09% above its 50-day average, and the 50-day average is 51.79% above the 200-day. Revenue growth holds it back most: revenue grew 10.60%, 13.6 percentage points slower than the sector median. The 50-day average stands at $179.90 and the 200-day at $118.52. Over the past year the price rose 113.50%.
Only on CleaRank
Figures we compute ourselves from OKTA's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $187.26 is 4.1% above the 50-day simple moving average of $179.90.Price above its 200-day average ›
The price is 58.0% above the 200-day simple moving average of $118.52.50-day average above the 200-day ›
The 50-day average ($179.90) is 51.8% above the 200-day average ($118.52), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 72% of its 52-week range, between $62.66 and $235.00.
OKTA share price
Pick a period: each tab shows how far OKTA has moved over it, to the last close.
Today's trading
Where OKTA sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
2/4P/E below the sector median ›
The trailing P/E of 112.81 is 221.4% above the Technology median of 35.1.P/S below the sector median ›
The price-to-sales ratio of 10.65 is 40.2% above the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $296.0M on revenue of $3.1B, a net margin of 9.6%.Beat estimates in most recent reports ›
OKTA beat the EPS estimate in 7 of its last 7 reports.
Key statistics
The headline figures for OKTA.
As of October 17, 2026, OKTA trades at $187.26, with a market value of $32.74B and a P/E ratio of 112.81.
What the numbers say
CleaRank Financial AI's reading of OKTA's valuation, growth and risks.
OKTA's P/E of 112.81 is 221.4% above the Technology sector median P/E of 35.1, a premium to peers by that measure. Looking at sales, the P/S of 10.65 is 40.1% above the sector median P/S of 7.6. The company's market capitalisation stands at $32.7B.
In the latest year revenue grew 10.60%, 13.6 percentage points slower than the sector median of 24.2%. The business earns a net margin of 9.63% and an operating margin of 13.29% and a return on equity of 4.31%, below the sector median of 13.4%. Debt-to-equity of 0.01 rounds out the fundamentals.
OKTA's August 26, 2026 report topped expectations by 9.38%, with $1.05 per share reported against an estimate of $0.96. Investors responded: the stock climbed 28.63% in the next session.
OKTA has beaten the EPS estimate in all 7 of its recent reports, though the stock still fell in the first session after 1 of those 7 beats. The largest of the earlier reactions came after the March 4, 2026 report, which beat the estimate by 5.88% while the stock rose 11.03%. Analysts' average EPS estimate for this fiscal year is $3.93, which would be growth of 12.3%, and $4.38 for next year (growth of 11.4%).
OKTA's daily returns have a 30-day standard deviation of 4.07%. Valuation offers little cushion: the P/E of 112.81 sits 221.4% above the sector median, a premium to peers. The price is 20.31% below the 52-week high of $235.00. Insiders sold $68.4M of stock over the last 18 months and bought $267K. Since sales may be planned or made to cover taxes on vesting shares, they signal less than open-market buying would.
OKTA against the Technology sector
How OKTA compares with the median Technology stock CleaRank tracks.
Price to earnings vs sector: OKTA trades at a significant premium to sector peers (+221%), suggesting market expectations for superior growth or market position.
Return vs XLK: Since May 6, 2025, OKTA has gained 60.0% against a gain of 71.7% for XLK.
Performance against XLK
OKTA and the Technology sector fund over the same days.
Revenue and earnings
How much OKTA sells, and how much of it becomes profit.
Revenue growth: Revenue grew 11.8% in FY2026 to $2.9B, from $2.6B a year earlier.
Profit margin: The net margin was 8.1% in FY2026, up from 1.1% the year before.
Profitable: OKTA earned $235M in FY2026.
Earnings reality check
Did OKTA beat what analysts expected, and how did the stock react?
Earnings record: OKTA beat the analyst estimate in 7 of the last 7 quarters.
Market reaction: The stock fell in the first session after 1 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 26, 2026after close | $0.96 | $1.05 | +9.38% | +28.63% | +21.37% |
| Mar 4, 2026after close | $0.85 | $0.90 | +5.88% | +11.03% | +12.70% |
| Dec 2, 2025after close | $0.76 | $0.82 | +7.89% | +5.46% | +7.23% |
| Aug 26, 2025after close | $0.85 | $0.91 | +7.06% | +1.61% | -1.90% |
| May 27, 2025after close | $0.77 | $0.86 | +11.69% | -16.16% | -17.47% |
| Mar 3, 2025after close | $0.74 | $0.78 | +5.41% | +24.27% | +20.69% |
| Dec 3, 2024after close | $0.58 | $0.67 | +15.52% | +5.38% | +1.31% |
As of October 17, 2026, OKTA has beaten the analyst EPS estimate in 7 of its last 7 reported quarters and fell in the first trading session after 1 of those beats; its latest report, on August 26, 2026, came in 9.38% above the estimate and the stock moved +28.63% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 41.5, in neutral territory.RSI above 50 ›
An RSI of 41.5 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of OKTA
The score, the reasoning behind it, and what could move the price next.
Trend is firmly up for OKTA. At $187.26, the stock sits 4.09% above its 50-day average of $179.90 and 58.00% above its 200-day average of $118.52. Its position is 72% of the 52-week range, which leaves the price 20.31% below the 52-week high of $235.00. The 50-day average is also 51.79% above the 200-day average.
The recent dip sits within a much stronger longer record. Over the past month the price slipped 0.46%, yet over the past three months it climbed 25.38% and over the past year 113.50%. In the last session the price dropped 10.20%, on volume that was 115.0% above its average. Momentum is balanced: the 14-day RSI sits at 41.5, in the neutral zone, and the MACD line is positive.
Earnings beat ›
The August 26, 2026 report beat the EPS estimate by 9.38%, and the share price rose 28.63% in the first session after it.
Source: Earnings report, August 26, 2026Rating reaffirmed ›
BMO Capital kept its Outperform rating on October 9, 2026.
Source: Analyst action, BMO Capital, October 9, 2026
New analyst coverage ›
Amerx started coverage at Hold on October 8, 2026.
Source: Analyst action, Amerx, October 8, 2026
- The two closest levels matter most: the 20-day EMA at $206.50 overhead and the 50-day SMA at $179.90 underneath the price.
- The 14-day RSI is 41.5, which is neutral, and the MACD line is positive. Readings above 70 or below 30 would signal stretched momentum.
- OKTA's share price climbed 28.63% in the first session after the August 26, 2026 report, and the stock has beaten estimates in 7 of the last 7 reports.
OKTA trades above its 50-day and 200-day moving averages ($179.90 and $118.52), which is what makes the trend up; losing the 50-day would be the first warning. The nearest level under the price is the 50-day SMA at $179.90.
The first level the price meets on the way up is the 20-day EMA, at $206.50.
Technical indicators
Momentum and trend for OKTA, from its daily closes.
As of October 17, 2026, with OKTA at $187.26, its 14-day RSI is 41.5 (neutral territory), its 50-day simple moving average is $179.90 and its 200-day is $118.52.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What OKTA moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, OKTA's 1-year correlation of daily returns is +0.36 with S&P 500 (SPY), +0.38 with Nasdaq 100 (QQQ), +0.17 with Bitcoin (BTC) and +0.01 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
34 of 44 analysts rate it a buy or strong buy, 10 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $223.00 is 19.1% above the price.More buy ratings than three months ago ›
34 of 44 rate it a buy now, against 33 of 44 three months ago.
OKTA Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 9, 2026 | BMO Capital | Maintains | Outperform |
| Oct 8, 2026 | Amerx | Initiates | Hold |
| Sep 29, 2026 | Morgan Stanley | Maintains | Overweight |
| Sep 28, 2026 | Scotiabank | Maintains | Sector Outperform |
| Sep 28, 2026 | Citizens | Maintains | Market Outperform |
| Sep 25, 2026 | Macquarie | Maintains | Outperform |
As of October 17, 2026, 44 Wall Street analysts cover OKTA: 34 rate it a buy or strong buy, 10 a hold and 0 a sell or strong sell. Their 12-month price targets range from $127.00 to $250.00, with a median of $223.00, 19.1% above the price of $187.26.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
OKTA trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
OKTA moves about 4.1% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much OKTA tends to move, against the market and on its own.
The long record
OKTA's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 4.07% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 84.2%, from February 2021 to November 2022; the price is still 34.3% below that peak.Most 1-year holds ended higher ›
72% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in April 2017 is now worth $79,651, against $37,590 in the S&P 500 (SPY).
OKTA Drawdowns & Recovery
As of October 17, 2026, OKTA's worst peak-to-trough fall over the last 10 years with dividends reinvested was -84.2% (February 2021 to November 2022); it is still 34.3% below that peak, and 72% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into OKTA in April 2017 is worth now, against the same amount in the S&P 500.
Against the market: OKTA beat the S&P 500 over this period: $79,651 against $37,590.
A $10,000 investment in OKTA in April 2017 would be worth about $79,651 today with dividends reinvested, compared with about $37,590 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to OKTA, and which have not.
Strongest month, April: an average of +8.07%, up in 7 of 9 years.
Weakest month, September: an average of -3.64%, up in 4 of 10 years.
This month, October: has averaged -2.58%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, OKTA's strongest calendar month has been April (average +8.07%, up in 7 of 9 years) and its weakest September (average -3.64%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in OKTA, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in OKTA today could grow to about $27,969 by 2036 in the base case, with a 90th-percentile outcome near $212,189 and a 10th-percentile outcome around $3,687. Projections are statistical simulations, not guarantees.
OKTA Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $283 for OKTA by 2030 in the base case, from $187 today (1.5x over 4 years). The 10th-percentile path ends near $78.44. These are outcomes of a Monte Carlo simulation run on OKTA's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $109 | $208 | $394 | |
| 2028 | $92.94 | $230 | $569 | |
| 2029 | $84.03 | $255 | $774 | |
| 2030 | $78.44 | $283 | $1,018 | |
| 2031 | $74.73 | $313 | $1,312 |
Method: a lognormal simulation of OKTA's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. OKTA is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation.
Insider trading
What the people running the company have bought and sold.
OKTA insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $267K on the open market and sold $68.4M.
As of October 17, 2026, OKTA insiders reported 40 open-market sales worth $68.4M and 1 open-market purchase worth $267K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 22, 2026 | Todd Mckinnon
Chief Executive Officer
|
Sell | 48.8K | $9.4M |
| Sep 18, 2026 | Eric Robert Kelleher
President
|
Sell | 6.4K | $1.2M |
| Sep 15, 2026 | Eric Robert Kelleher
President
|
Grant | 16.3K | - |
| Sep 11, 2026 | Eric Robert Kelleher
President
|
Sell | 2.5K | $429.6K |
| Sep 9, 2026 | Jacques Frederic Kerrest
Director
|
Grant | 6.0K | - |
| Sep 4, 2026 | Jacques Frederic Kerrest
Director
|
Grant | 6.0K | - |
| Sep 2, 2026 | Brett Tighe
Chief Financial Officer
|
Sell | 80.0K | $12.9M |
| Sep 2, 2026 | Brett Tighe
Chief Financial Officer
|
Grant | 41.3K | - |
| Aug 13, 2026 | David R Schellhase
Director
|
Grant | 1.9K | - |
| Jul 8, 2026 | Todd Mckinnon
Chief Executive Officer
|
Sell | 68.9K | $10.1M |
| Jun 22, 2026 | Larissa Nicole Schwartz
Officer
|
Sell | 2.5K | $295.6K |
| Jun 18, 2026 | Eric Robert Kelleher
President
|
Sell | 4.0K | $453.8K |
| Jun 18, 2026 | Anthony John Bates
Director
|
Grant | 4.5K | - |
| Jun 18, 2026 | Jacques Frederic Kerrest
Director
|
Grant | 6.8K | - |
| Jun 17, 2026 | Shellye L Archambeau
Director
|
Option | 2.5K | $281.1K |
| Jun 17, 2026 | Shellye L Archambeau
Director
|
Grant | 2.5K | - |
| Jun 17, 2026 | Emilie Monica Choi
Director
|
Grant | 2.5K | - |
| Jun 17, 2026 | Robert L Dixon Jr
Director
|
Grant | 2.5K | - |
| Jun 17, 2026 | Jeffrey Emanuel Epstein
Director
|
Grant | 2.5K | - |
| Jun 17, 2026 | Jacques Frederic Kerrest
Director
|
Grant | 8.8K | - |
| Jun 16, 2026 | Shibu Ninan
Officer
|
Grant | 2.5K | - |
| Jun 15, 2026 | Jonathan James Addison
Officer
|
Grant | 12.7K | - |
| Jun 15, 2026 | Eric Robert Kelleher
President
|
Grant | 16.3K | - |
| Jun 15, 2026 | Todd Mckinnon
Chief Executive Officer
|
Grant | 21.0K | - |
| Jun 15, 2026 | Shibu Ninan
Officer
|
Grant | 4.6K | - |
| Jun 15, 2026 | Larissa Nicole Schwartz
Officer
|
Grant | 8.6K | - |
| Jun 15, 2026 | Brett Tighe
Chief Financial Officer
|
Grant | 12.0K | - |
| Jun 8, 2026 | Brett Tighe
Chief Financial Officer
|
Sell | 65.0K | $7.6M |
| Jun 2, 2026 | Larissa Nicole Schwartz
Officer
|
Sell | 25.0K | $3.3M |
| May 18, 2026 | Shellye L Archambeau
Director
|
Sell | 2.5K | $212.5K |
| May 7, 2026 | Larissa Nicole Schwartz
Officer
|
Sell | 6.4K | $494.5K |
| Apr 16, 2026 | David R Schellhase
Director
|
Buy | 3.7K | $267.4K |
| Apr 7, 2026 | Larissa Nicole Schwartz
Officer
|
Sell | 6.4K | $508.6K |
| Apr 1, 2026 | Eric Robert Kelleher
President
|
Sell | 2.4K | $192.7K |
| Apr 1, 2026 | Eric Robert Kelleher
President
|
Grant | 2.4K | - |
| Mar 25, 2026 | Jonathan James Addison
Officer
|
Sell | 23.3K | $1.8M |
| Mar 23, 2026 | Todd Mckinnon
Chief Executive Officer
|
Sell | 11.3K | $912.4K |
| Mar 19, 2026 | Eric Robert Kelleher
President
|
Sell | 16.8K | $1.3M |
| Mar 13, 2026 | Jonathan James Addison
Officer
|
Grant | 12.3K | - |
| Mar 13, 2026 | Eric Robert Kelleher
President
|
Grant | 21.3K | - |
| Mar 13, 2026 | Jacques Frederic Kerrest
Director
|
Grant | 843 | - |
| Mar 13, 2026 | Todd Mckinnon
Chief Executive Officer
|
Grant | 22.9K | - |
| Mar 13, 2026 | Shibu Ninan
Officer
|
Grant | 4.1K | - |
| Mar 13, 2026 | Larissa Nicole Schwartz
Officer
|
Grant | 9.6K | - |
| Mar 13, 2026 | Brett Tighe
Chief Financial Officer
|
Grant | 18.3K | - |
| Mar 10, 2026 | Larissa Nicole Schwartz
Officer
|
Sell | 1.8K | $146.7K |
| Feb 25, 2026 | Jonathan James Addison
Officer
|
Grant | 18.1K | - |
| Feb 25, 2026 | Eric Robert Kelleher
President
|
Grant | 21.1K | - |
| Feb 25, 2026 | Todd Mckinnon
Chief Executive Officer
|
Grant | 193.9K | - |
| Feb 25, 2026 | Shibu Ninan
Officer
|
Grant | 8.4K | - |
| Feb 25, 2026 | Larissa Nicole Schwartz
Officer
|
Grant | 44.9K | - |
| Feb 25, 2026 | Brett Tighe
Chief Financial Officer
|
Grant | 64.8K | - |
| Feb 6, 2026 | Larissa Nicole Schwartz
Officer
|
Sell | 1.8K | $153.3K |
| Jan 13, 2026 | Brett Tighe
Chief Financial Officer
|
Sell | 10.0K | $950.7K |
| Jan 13, 2026 | Shibu Ninan
Officer
|
Sell | 1.1K | $99.9K |
| Jan 7, 2026 | Larissa Nicole Schwartz
Officer
|
Sell | 1.9K | $172.3K |
| Jan 2, 2026 | Eric Robert Kelleher
President
|
Sell | 2.4K | $203.3K |
| Jan 2, 2026 | Eric Robert Kelleher
President
|
Grant | 2.4K | - |
| Dec 22, 2025 | Todd Mckinnon
Chief Executive Officer
|
Sell | 11.3K | $1.0M |
| Dec 22, 2025 | Eric Robert Kelleher
President
|
Sell | 8.5K | $766.5K |
| Dec 15, 2025 | Jonathan James Addison
Officer
|
Grant | 13.4K | - |
| Dec 15, 2025 | Eric Robert Kelleher
President
|
Grant | 21.3K | - |
| Dec 15, 2025 | Jacques Frederic Kerrest
Director
|
Grant | 842 | - |
| Dec 15, 2025 | Todd Mckinnon
Chief Executive Officer
|
Grant | 22.9K | - |
| Dec 15, 2025 | Shibu Ninan
Officer
|
Grant | 4.1K | - |
| Dec 15, 2025 | Larissa Nicole Schwartz
Officer
|
Grant | 9.9K | - |
| Dec 15, 2025 | Brett Tighe
Chief Financial Officer
|
Grant | 18.3K | - |
| Dec 10, 2025 | Jacques Frederic Kerrest
Director
|
Grant | 83.0K | - |
| Dec 8, 2025 | Jacques Frederic Kerrest
Director
|
Grant | 83.5K | - |
| Dec 5, 2025 | Larissa Nicole Schwartz
Officer
|
Sell | 1.3K | $113.0K |
| Nov 11, 2025 | Larissa Nicole Schwartz
Officer
|
Sell | 1.3K | $112.4K |
| Oct 8, 2025 | Larissa Nicole Schwartz
Officer
|
Sell | 1.3K | $120.8K |
| Oct 2, 2025 | Brett Tighe
Chief Financial Officer
|
Sell | 10.0K | $950.0K |
| Oct 1, 2025 | Eric Robert Kelleher
President
|
Sell | 2.4K | $221.1K |
| Oct 1, 2025 | Eric Robert Kelleher
President
|
Grant | 2.4K | - |
| Sep 25, 2025 | Jacques Frederic Kerrest
Director
|
Grant | 73.0K | - |
| Sep 23, 2025 | Jacques Frederic Kerrest
Director
|
Grant | 73.0K | - |
| Sep 22, 2025 | Todd Mckinnon
Chief Executive Officer
|
Sell | 32.0K | $3.0M |
| Sep 22, 2025 | Todd Mckinnon
Chief Executive Officer
|
Option | 17.1K | $1.6M |
| Sep 18, 2025 | Eric Robert Kelleher
President
|
Sell | 8.5K | $789.3K |
| Sep 18, 2025 | Jonathan James Addison
Officer
|
Sell | 6.1K | $564.1K |
| Sep 17, 2025 | Larissa Nicole Schwartz
Officer
|
Sell | 3.3K | $301.9K |
| Sep 15, 2025 | Jonathan James Addison
Officer
|
Grant | 13.4K | - |
| Sep 15, 2025 | Eric Robert Kelleher
President
|
Grant | 21.6K | - |
| Sep 15, 2025 | Jacques Frederic Kerrest
Director
|
Grant | 843 | - |
| Sep 15, 2025 | Todd Mckinnon
Chief Executive Officer
|
Grant | 22.9K | - |
| Sep 15, 2025 | Shibu Ninan
Officer
|
Grant | 4.1K | - |
| Sep 15, 2025 | Larissa Nicole Schwartz
Officer
|
Grant | 9.9K | - |
| Sep 15, 2025 | Brett Tighe
Chief Financial Officer
|
Grant | 18.3K | - |
| Aug 19, 2025 | Emilie Monica Choi
Director
|
Grant | 1.2K | - |
| Jul 28, 2025 | Larissa Nicole Schwartz
Officer
|
Grant | 14.0K | - |
| Jul 25, 2025 | Jonathan James Addison
Officer
|
Sell | 9.0K | $900.0K |
| Jul 21, 2025 | Todd Mckinnon
Chief Executive Officer
|
Sell | 31.6K | $3.0M |
| Jul 21, 2025 | Todd Mckinnon
Chief Executive Officer
|
Option | 5.4K | $213.2K |
| Jul 18, 2025 | Brett Tighe
Chief Financial Officer
|
Sell | 10.0K | $950.0K |
| Jul 15, 2025 | Eric Robert Kelleher
President
|
Sell | 16.0K | $1.5M |
| Jul 15, 2025 | Jonathan James Addison
Officer
|
Sell | 9.0K | $830.0K |
| Jul 15, 2025 | Eric Robert Kelleher
President
|
Grant | 2.4K | - |
| Jun 20, 2025 | Larissa Nicole Schwartz
Officer
|
Sell | 3.3K | $333.2K |
| Jun 20, 2025 | Jacques Frederic Kerrest
Director
|
Sell | 581 | $58.3K |
| Jun 20, 2025 | Shellye L Archambeau
Director
|
Grant | 2.8K | - |
| Jun 20, 2025 | Anthony John Bates
Director
|
Grant | 2.0K | - |
| Jun 20, 2025 | Emilie Monica Choi
Director
|
Grant | 2.8K | - |
| Jun 20, 2025 | Robert L Dixon Jr
Director
|
Grant | 2.8K | - |
| Jun 20, 2025 | Jeffrey Emanuel Epstein
Director
|
Grant | 2.8K | - |
| Jun 20, 2025 | Benjamin A Horowitz
Director
|
Grant | 2.8K | - |
| Jun 20, 2025 | Jacques Frederic Kerrest
Director
|
Grant | 2.8K | - |
| Jun 20, 2025 | Rebecca Saeger
Director
|
Grant | 2.8K | - |
| Jun 20, 2025 | Michael A Stankey
Director
|
Grant | 2.8K | - |
| Jun 13, 2025 | Jonathan James Addison
Officer
|
Grant | 13.4K | - |
| Jun 13, 2025 | Eric Robert Kelleher
President
|
Grant | 21.6K | - |
| Jun 13, 2025 | Jacques Frederic Kerrest
Director
|
Grant | 842 | - |
| Jun 13, 2025 | Jacques Frederic Kerrest
Director
|
Grant | 130.0K | - |
| Jun 13, 2025 | Todd Mckinnon
Chief Executive Officer
|
Grant | 22.9K | - |
| Jun 13, 2025 | Shibu Ninan
Officer
|
Grant | 4.1K | - |
| Jun 13, 2025 | Larissa Nicole Schwartz
Officer
|
Grant | 9.9K | - |
| Jun 13, 2025 | Brett Tighe
Chief Financial Officer
|
Grant | 18.3K | - |
| Jun 11, 2025 | Jacques Frederic Kerrest
Director
|
Grant | 130.0K | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.